SHYFT

About:

SHYFT helps life science companies integrate clinical and commercial data and translate it into patient-centric intelligence and analytics

Website: http://shyftanalytics.com/

Twitter/X: shyftanalytics

Top Investors: Health Enterprise Partners, Optum Ventures, McKesson Ventures, Activate Venture Partners, McKesson

Description:

SHYFT is an integral part of the life sciences ecosystem and as the market undergoes a dramatic transformation to deliver more personalized and value-based medicine, the role of SHYFT has never been more important. The SHYFT Platform helps life science companies integrate clinical and commercial data and translate it into patient-centric intelligence and analytics for use across functional groups, shortening development cycles and commercialization activities while improving the probability of success.

Total Funding Amount:

$58M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)shyftanalytics.com

Founders:

Zackary King

Number of Employees:

101-250

Last Funding Date:

2017-03-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai